Jiang, Shuangying http://orcid.org/0000-0002-6786-6533
Luo, Zhouqing
Wu, Jie http://orcid.org/0000-0003-4659-4273
Yu, Kang
Zhao, Shijun
Cai, Zelin http://orcid.org/0000-0001-6409-7938
Yu, Wenfei http://orcid.org/0000-0002-1196-6236
Wang, Hui
Cheng, Li
Liang, Zhenzhen
Gao, Hui
Monti, Marco http://orcid.org/0000-0003-1266-4325
Schindler, Daniel http://orcid.org/0000-0001-7423-6540
Huang, Linsen
Zeng, Cheng
Zhang, Weimin http://orcid.org/0000-0002-8836-1438
Zhou, Chun
Tang, Yuanwei
Li, Tianyi
Ma, Yingxin
Cai, Yizhi http://orcid.org/0000-0003-1663-2865
Boeke, Jef D. http://orcid.org/0000-0001-5322-4946
Zhao, Qiao http://orcid.org/0000-0002-0958-4300
Dai, Junbiao http://orcid.org/0000-0002-5299-4700
Article History
Received: 11 July 2023
Accepted: 13 November 2023
First Online: 30 November 2023
Competing interests
: J.D.B. is a founder of Neochromosome, Inc. and a Founder and Director of CDI Labs, Inc, a Founder, SAB member of and consultant to ReOpen Diagnostics, LLC and serves or served on the Scientific Advisory Board of the following: Logomix, Inc., Sangamo, Inc., Modern Meadow, Inc., Rome Therapeutics, Inc., Sample6, Inc., Tessera Therapeutics, Inc. and the Wyss Institute. The remaining authors declare no competing interests.